News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News

04/21/2022

Using NLP Technology To Uncover Real-World Patient Insights

By Tiffany Druley

It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years.

Read

01/13/2022

Dr. Ali on the Need to Understand Real-World Disparities in BRCA Testing in TNBC

By Tiffany Druley

During the 2021 San Antonio Breast Cancer Symposium, findings from a real-world analysis evaluating racial disparities in BRCA testing for patients with TNBC were presented in a virtual poster. The results showed that the rate of BRCA testing was high overall in evaluated patients with TNBC, although a larger proportion of White patients received testing compared with Black or African American patients.

Read

01/10/2022

Achieving Comprehensive Patient Care Using Natural Language Processing

By Tiffany Druley

Telehealth has seen unprecedented growth within the past few years. As a result of this adoption, at the onset of the COVID-19 pandemic, health care organizations were quickly able to adapt their processes from being rooted in in-person care to relying on virtual care.

Read

Load more

Press Releases

04/07/2022

Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership

By Chris Burkhardt

Washington, D.C.(April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE).

Read

03/31/2022

Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role

By Antoinette Cummins

SAN FRANCISCO, March 31, 2022 — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that long-time board member and health industry veteran Frank Williams has been named as Chairman of the company’s board of directors. Additionall…

Read

03/22/2022

Main Line Health Collaborates with Syapse, Bringing Clinical Trial Opportunities to Patients with Cancer in Philadelphia Region

By Tiffany Druley

San Francisco, CA – March 17, 2022 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a collaboration with Main Line Health, home to four of the Philadelphia region’s most respected acute care hospitals. Main Line Health will utilize the Syapse…

Read

Load more

Events

Webinar

The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care

March 10, 2022

Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.